Increasing glutathione levels for therapy

Abstract

The present invention concerns compositions and methods related to utilizing glycine and N-acetylcysteine for a variety of methods, including, for example, reducing deleterious effects of oxidative stress; treating and/or preventing diabetes; and/or increasing GSH levels.

The claimed invention is: 
     
         1 . A composition:
 (a) consisting essentially of glycine and N-acetylcysteine; or   (b) consisting of glycine and n-acetylcysteine.   
     
     
         2 . A method of reducing deleterious effects of oxidative stress in an individual, comprising the steps of providing an effective amount of glycine and N-acetylcysteine to the individual. 
     
     
         3 . The method of  claim 2 , wherein the individual is receiving treatment or has received treatment for diabetes. 
     
     
         4 . A method of treating and/or preventing diabetes in an individual, comprising the step of providing an effective amount of glycine and n-acetylcysteine to the individual. 
     
     
         5 . The method of  claim 4 , wherein the glycine and n-acetylcysteine are provided to the individual in the same composition. 
     
     
         6 . The method of  claim 4 , wherein the glycine and n-acetylcysteine are provided orally to the individual. 
     
     
         7 . A method of treating and/or preventing a medical condition in an individual, wherein the medical condition is associated with reduced glutathione levels, comprising the steps of:
 a) identifying an individual in need of treatment of the medical condition; and   b) providing an effective amount of glycine and N-acetylcysteine to the individual.   
     
     
         8 . The method of  claim 7 , wherein the medical condition is diabetes or complications of diabetes. 
     
     
         9 . A method of increasing GSH levels in an individual in need thereof, comprising the step of providing an effective amount of glycine and n-acetylcysteine to the individual, wherein the individual in need thereof is at least sixty years of age and/or has diabetes. 
     
     
         10 . A method of reducing body weight, lowering cholesterol level, and/or lowering triglyceride level in an individual, comprising the step of providing an effective amount of glycine and n-acetylcysteine to the individual. 
     
     
         11 . A method of treating an individual for one or more medical conditions, comprising the step of providing an effective amount of glycine and n-acetylcysteine to the individual, wherein the medical condition comprises:
 (a) dyslipidemia and/or insulin resistance;   (b) obesity;   (c) fatty acid oxidation;   (d) diabetic dyslipidemia;   (e) elevated fatty acid levels;   (f) diabetic microvascular complication comprising nephropathy, retinopathy, and/or neuropathy;   (g) elevated cholesterol and/or triglyceride levels;   (h) fatty liver disease;   (i) neurodegenerative disease in aging; and/or   (j) statin-induced myopathy.